Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Jul 5;77(1):9-15.
doi: 10.1093/cid/ciad112.

Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias

Affiliations
Multicenter Study

Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias

Thomas W van der Vaart et al. Clin Infect Dis. .

Abstract

Background: Several studies have suggested that in patients with Staphylococcus aureus bacteremia (SAB) [18F] fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) improves outcome. However, these studies often ignored possible immortal time bias.

Methods: Prospective multicenter cohort study in 2 university and 5 non-university hospitals, including all patients with SAB. [18F]FDG-PET/CT was performed on clinical indication as part of usual care. Primary outcome was 90-day all-cause mortality. Effect of [18F]FDG-PET/CT was modeled with a Cox proportional hazards model using [18F]FDG-PET/CT as a time-varying variable and corrected for confounders for mortality (age, Charlson score, positive follow-up cultures, septic shock, and endocarditis). Secondary outcome was 90-day infection-related mortality (assessed by adjudication committee) using the same analysis. In a subgroup-analysis, we determined the effect of [18F]FDG-PET/CT in patients with high risk of metastatic infection.

Results: Of 476 patients, 178 (37%) underwent [18F]FDG-PET/CT. Day-90 all-cause mortality was 31% (147 patients), and infection-related mortality was 17% (83 patients). The confounder adjusted hazard ratio (aHR) for all-cause mortality was 0.50 (95% confidence interval [CI]: .34-.74) in patients that underwent [18F]FDG-PET/CT. Adjustment for immortal time bias changed the aHR to 1.00 (95% CI .68-1.48). Likewise, after correction for immortal time bias, [18F]FDG-PET/CT had no effect on infection-related mortality (cause specific aHR 1.30 [95% CI .77-2.21]), on all-cause mortality in patients with high-risk SAB (aHR 1.07 (95% CI .63-1.83) or on infection-related mortality in high-risk SAB (aHR for 1.24 [95% CI .67-2.28]).

Conclusions: After adjustment for immortal time bias [18F]FDG-PET/CT was not associated with day-90 all-cause or infection-related mortality in patients with SAB.

Keywords: Staphylococcus aureus bacteraemia; [18F]FDG-PET/CT; immortal time bias; mortality.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. M. J. B. reports funding through grants or contracts to the author's institution from Janssen Vaccines, Novaritis, CureVac, and Merck; payment or honoraria made to the author from Takeda; and participation on a Data Safety Monitoring or Advisory Board for Sanofi, Spherecydes, Pfizer, Merck, Novartis, and Astra-Zeneca for unrelated works. C. H. W. reports funding through grants or contracts from DaVolterra, bioMérieux, and LimmaTech, as well as consulting fees from Merck/MSD and Sanofi-Pasteur for unrelated works, all of which were paid to the author's institution. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

None
This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/positive-impact-of-18f-fdg-pet-ct-on-mortality-in-patients-with-staphylococcus-aureus-bacteremia-explained-by-immortal-time-bias-b4db7e26-22b3-4771-bad6-9eba9b0c3dcc/update
Figure 1.
Figure 1.
Kaplan-Meier survival curves with PET/CT as a time-fixed effect. A, The Kaplan-Meier curves with PET/CT as a time-fixed effect. B, Magnification of the first 7 days which clearly demonstrate risk of immortal time bias, as no deaths occur in the PET/CT group in the first 7 days, while in the no PET/CT group 24% of total deaths (n = 25) occur in the first 7 days. C, The effect of drawing the Kaplan-Meier curves after 7 days, demonstrating that after this time period the curves are nearly overlapping. Abbreviation: PET/CT, positron emission tomography/computed tomography.

Comment in

Similar articles

Cited by

References

    1. Le Moing V, Alla F, Doco-Lecompte T, et al. . Staphylococcus aureus bloodstream infection and endocarditis—a prospective cohort study. PLoS One 2015; 10:e0127385. - PMC - PubMed
    1. Kaasch AJ, Barlow G, Edgeworth JD, et al. . Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect 2014; 68:242–51. - PMC - PubMed
    1. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012; 25:362–86. - PMC - PubMed
    1. Berrevoets MAH, Kouijzer IJE, Aarntzen E, et al. . [18F]FDG PET/CT optimizes treatment in Staphylococcus aureus bacteremia and is associated with reduced mortality. J Nucl Med 2017; 58:1504–10. - PubMed
    1. Ghanem-Zoubi N, Kagna O, Abu-Elhija J, et al. . Integration of FDG-PET/CT in the diagnostic workup for Staphylococcus aureus bacteremia: a prospective interventional matched-cohort study. Clin Infect Dis 2021; 73:e3859–66. - PubMed

Publication types

Substances